In addition, somatic mutations in CALR (calreticulin), MPL (MPL proto-oncogene, thrombopoietin receptor), and TET2 (Tet methylcytosine dioxygenase 2) genes are also detected in patients with MPN (4). The gene discussed is MPL; the disease is myeloproliferative disorder.